QUINOXALINE AND QUINOLINE DERIVATIVES AS KINASE INHIBITORS
申请人:Allen Daniel Rees
公开号:US20110105508A1
公开(公告)日:2011-05-05
A series of heteroaryl-substituted quinoxaline and quinoline derivatives, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.
[EN] QUINOXALINE AND QUINOLINE DERIVATIVES AS KINASE INHIBITORS<br/>[FR] DÉRIVÉS DE QUINOXALINE ET DE QUINOLÉINE EN TANT QU'INHIBITEURS DE KINASE
申请人:UCB PHARMA SA
公开号:WO2009081105A3
公开(公告)日:2009-08-20
US8399483B2
申请人:——
公开号:US8399483B2
公开(公告)日:2013-03-19
Quinoxaline and quinoline derivatives as kinase inhibitors
申请人:Allen Daniel Rees
公开号:US08399483B2
公开(公告)日:2013-03-19
A series of heteroaryl-substituted quinoxaline and quinoline derivatives, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions, said substituted derivatives having the general formula